Genetic Technologies Ltd - ESG Rating & Company Profile powered by AI
This ESG rating for Genetic Technologies Ltd indicates its reporting of the United Nations Sustainable Development Goals. Comprehensive Sustainability analysis of Genetic Technologies Ltd are reached by signing up for free. Jump to the end of this page for potential risks for Genetic Technologies Ltd based on industry, geography and size.
Genetic Technologies Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.7; made up of an environmental score of 4.0, social score of 8.0 and governance score of 8.0.
6.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 314 | Trulieve Cannabis Corp | 6.8 | High |
| 314 | Vicore Pharma Holding AB | 6.8 | High |
| 337 | Genetic Technologies Ltd | 6.7 | High |
| 337 | Calyxt Inc | 6.7 | High |
| 337 | CanSino Biologics Inc | 6.7 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Genetic Technologies Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Genetic Technologies Ltd report the average age of the workforce?
Sign up for free to unlockDoes Genetic Technologies Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Genetic Technologies Ltd offer flexible work?
Sign up for free to unlockDoes Genetic Technologies Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Genetic Technologies Ltd conduct supply chain audits?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Genetic Technologies Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose water use targets?
Sign up for free to unlockDoes Genetic Technologies Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Genetic Technologies Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Genetic Technologies Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Genetic Technologies Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Genetic Technologies Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Genetic Technologies Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Genetic Technologies Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose its waste policy?
Sign up for free to unlockDoes Genetic Technologies Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose energy use targets?
Sign up for free to unlockDoes Genetic Technologies Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Genetic Technologies Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Genetic Technologies Ltd
These potential risks are based on the size, segment and geographies of the company.
Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include colorectal cancer, ovarian cancer, prostate cancer, coronary artery, and type 2 diabetes. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.